Coronavirus Vaccine Data Are Targets for Foreign Hackers

Intelligence officials from the US, UK, and Canada point the finger at Cozy Bear, a group with links to the Russian government.

Written byAmanda Heidt
| 2 min read
cybersecurity, hacking, COVID-19, pandemic, coronavirus, SARS-CoV-2, vaccine, Russia, US, UK, Canada

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, JUSUN

Update (July 21): Today, the US Justice Department issued an indictment against two Chinese hackers linked to the country's intelligence services for attempting to steal proprietary COVID-19 vaccine information, The New York Times reports.

A hacking group affiliated with the Russian government is targeting academic institutions and pharmaceutical companies worldwide to glean information on COVID-19 vaccine research, according to Western powers. Intelligence officials from Britain, the United States, and Canada released a joint report this week condemning Cozy Bear—the same group responsible for email hacking during the 2016 US presidential election—for its use of malware to gain access to secure computers.

“We condemn these despicable attacks against those doing vital work to combat the coronavirus pandemic,” Paul Chichester, the director of operations for Britain’s National Cyber Security Centre (NCSC), says in a statement released alongside the report. The document goes on to state that Cozy Bear ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • amanda heidt

    Amanda first began dabbling in scicom as a master’s student studying marine science at Moss Landing Marine Labs, where she edited the student blog and interned at a local NPR station. She enjoyed that process of demystifying science so much that after receiving her degree in 2019, she went straight into a second master’s program in science communication at the University of California, Santa Cruz. Formerly an intern at The Scientist, Amanda joined the team as a staff reporter and editor in 2021 and oversaw the publication’s internship program, assigned and edited the Foundations, Scientist to Watch, and Short Lit columns, and contributed original reporting across the publication. Amanda’s stories often focus on issues of equity and representation in academia, and she brings this same commitment to DEI to the Science Writers Association of the Rocky Mountains and to the board of the National Association of Science Writers, which she has served on since 2022. She is currently based in the outdoor playground that is Moab, Utah. Read more of her work at www.amandaheidt.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies